查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
亚太地区放射性示踪剂市场预测至 2030 年 - 区域分析 - 按示踪剂类型、测试类型、应用和最终用户
市场调查报告书
商品编码
1420148

亚太地区放射性示踪剂市场预测至 2030 年 - 区域分析 - 按示踪剂类型、测试类型、应用和最终用户

Asia Pacific Radioactive Tracer Market Forecast to 2030 - Regional Analysis - by Tracer Type, Test Type, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 135 Pages | 订单完成后即时交付

价格

2022年亚太地区放射性示踪剂市值为16.158亿美元，预计2030年将达66.2961亿美元；预计2022年至2030年CAGR为19.3%。

慢性病盛行率上升推动亚太地区放射性示踪剂市场

人口老化的加剧、社会行为的改变、久坐生活方式的增加以及城市化进程的加速是导致肥胖和糖尿病等其他慢性病盛行率的关键因素。此外，研究早已证实基因可导致心血管疾病（CVD）、糖尿病、肥胖、阿兹海默症（AD）和忧郁症等慢性疾病。

忙碌的生活方式引起的动脉粥状硬化、心绞痛、急性心肌梗塞等心血管疾病已成为全球死亡的重要原因。根据世界卫生组织提供的资料，心血管疾病是全世界死亡的主要原因，每年估计有 1,790 万人死亡。糖尿病是一种危及生命的慢性疾病，无法进行功能性治癒。所有类型的糖尿病都会导致身体不同部位出现各种併发症，并增加过早死亡的整体风险。心臟病、中风、肾衰竭、截肢、视力丧失和神经损伤是与糖尿病相关的主要併发症。在预测期内，该疾病的盛行率可能会增加近 35%。

因此，有效的检查是正确治疗慢性病的必要条件；因此，核物质被用于诊断和检查目的。这些核物质用于正子断层扫描（PET）和单光子发射电脑断层扫描（SPECT）等诊断测试，以诊断神经系统疾病、心血管疾病、慢性肺部疾病和慢性肾臟病等慢性疾病。全球范围内有多种放射性示踪剂可供使用，因此可以根据疾病类型及其预后轻鬆进行选择。因此，慢性病发病率的增加导致对放射性示踪剂的需求激增，积极有利于市场扩张。

亚太地区放射性示踪剂市场概况

亚太地区放射性示踪剂市场分为澳洲、中国、印度、日本、韩国和亚太其他地区。由于新研究设施的发展、老年人口的增加以及混合系统随着领域技术进步的显着发展等因素，该地区的市场在预测期内可能会继续以最快的速度增长。

亚太地区放射性示踪剂市场收入及 2030 年预测（百万美元）

亚太地区放射性示踪剂市场细分

亚太地区放射性示踪剂市场根据示踪剂类型、测试类型、最终用户、应用和国家进行细分。根据示踪剂类型，亚太地区放射性示踪剂市场分为锝-99m和Tc-97m、碘-131、铁-59、镝-171、铷（Rb-82）氯化物和氨（N-13） 、钪-46、seaborgium-269、hassium-269、柠檬酸镓Ga 67、前列腺特异性膜抗原(PSMA) (Ga-68)、FDDNP (F-18) 和FDOPA (F-18)、磷-32和铬- 51、铊-201、F-18 FDG、F-18 FAPI、Ga-68 FAPI、F-18 PSMA、DOTATOC/DOTANOC/DOTATATE (Ga-68) 等。 2022 年，其他细分市场占据最大市场份额。

根据测试类型，亚太地区放射性追踪剂市场分为 PET、SPECT 等。 SPECT 细分市场在 2022 年占据最大的市场份额。

根据最终用户，亚太地区放射性示踪剂市场分为医院和诊所、诊断中心、学术和研究机构等。 2022 年，医院和诊所细分市场占据最大的市场。

根据应用，亚太地区放射性示踪剂市场分为肿瘤学、肺病学、神经病学、心臟病学等。 2022 年，肿瘤学领域占据最大的市场。

依国家/地区划分，亚太地区放射性示踪剂市场分为中国、日本、印度、澳洲、韩国和亚太地区其他地区。 2022年，中国在亚太地区放射性示踪剂市场占有率中占据主导地位。

Rotem Industries Ltd、Invicro LLC、Cardinal Health Inc、纽卡斯尔大学、诺华公司、Curium 和 IBA Radiopharma Solutions 是亚太地区放射性示踪剂市场的一些领先参与者。

目录

第 1 章：简介

  • Insight Partners 研究报告指南
  • 市场区隔

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：亚太地区放射性示踪剂市场 - 主要产业动态

  • 主要市场驱动因素：
    • 慢性病盛行率上升
    • 越来越多地使用核子成像技术
  • 市场限制
    • 放射性示踪剂的保存期限短
    • 核诊断影像程序替代品的可用性
  • 市场机会
    • 新兴经济体的存在与人口的成长
    • 用于标靶治疗的个人化放射性药物的开发
  • 未来的趋势
    • 放射性示踪剂在癌症诊断的应用
  • 影响分析：

第 5 章：放射性示踪剂市场 - 亚太地区市场分析

  • 放射性示踪剂市场收入，2022 - 2030

第 6 章：亚太地区放射性示踪剂市场 - 收入和 2030 年预测 - 按示踪剂类型

  • 概述
  • 2022 年及 2030 年放射性示踪剂市场收入份额，依示踪剂类型划分 (%)
  • 锝 99m 和 TC-97m
  • 碘131
  • 铁59
  • 镥- 171
  • RB82和氨N-13
  • 钪46
  • ?-269
  • 哈西姆-269
  • 柠檬酸镓 GA 67
  • PSMA GA68
  • FDDNP (F-18) 和 FDOPA (f-18)
  • 磷 32 和铬 -51
  • 铊201
  • F-18 FDG
  • F-18 FAPI
  • GA 68 FAPI
  • F-18 PSMA
  • DOTATOC/DOTANOC/DOTATATE Ga 68
  • 其他的

第 7 章：亚太地区放射性示踪剂市场 - 收入和 2030 年预测 - 按测试类型

  • 概述
  • 2022 年和 2030 年按测试类型分類的放射性示踪剂市场收入份额 (%)
  • 宠物
  • SPECT
  • 其他的

第 8 章：亚太地区放射性示踪剂市场 - 收入和 2030 年预测 -按应用。

  • 概述
  • 2022 年和 2030 年按应用分類的放射性示踪剂市场收入份额 (%)
  • 肿瘤学
  • 肺部
  • 神经病学
  • 心臟病学
  • 其他的

第 9 章：亚太地区放射性示踪剂市场 - 收入和 2030 年预测 - 按最终用户

  • 概述
  • 2022 年及 2030 年最终用户放射性示踪剂市场收入份额 (%)
  • 医院和诊所
  • 诊断中心
  • 学术及研究机构
  • 其他的

第 10 章：亚太地区放射性示踪剂市场 - 国家分析

    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区

第 11 章：放射性示踪剂市场产业格局

  • 概述
  • 有机发展
    • 概述
  • 无机发展
    • 概述

第 12 章：放射性示踪剂市场，主要公司概况

  • Rotem Industries Ltd
  • Invicro LLC
  • Cardinal Health Inc
  • Newcastle University
  • Novartis AG
  • Curium
  • General Electric Co
  • IBA Radiopharma Solutions

第 13 章：附录

  • 关于我们
  • 专业术语
Product Code: BMIRE00029110

The Asia Pacific radioactive tracer market was valued at US$ 1,615.80 million in 2022 and is expected to reach US$ 6,629.61 million by 2030; it is estimated to grow at a CAGR of 19.3% from 2022 to 2030.

Rising Prevalence of Chronic Diseases fuel the Asia Pacific Radioactive Tracer Market

Increasing aging population, changing social behavior, rising adoption of a sedentary lifestyle, and accelerating urbanization are the key factors boosting the prevalence of obesity and other chronic diseases such as diabetes. Further, studies have long established that genes can cause chronic conditions such as cardiovascular disease (CVD), diabetes, obesity, Alzheimer's disease (AD), and depression.

CVDs, such as atherosclerosis, angina pectoris, and acute myocardial infarction, caused due to hectic lifestyles have become significant causes of mortality worldwide. As per the data provided by the WHO, CVDs are the predominant cause of death worldwide, recording estimated 17.9 million deaths each year. Diabetes is a life-threatening chronic disease with no functional cure. Diabetes of all types can lead to various complications in different body parts and increase the overall risk of premature death. Heart attack, stroke, kidney failure, leg amputation, vision loss, and nerve damage are among the major complications associated with diabetes. The disease prevalence will likely increase by nearly 35% during the forecast period.

Thus, an effective examination is a must for properly treating chronic diseases; hence, nuclear substances are used for diagnosis and examination purposes. These nuclear substances are used in diagnostic tests such as positron emission tomography (PET) and single-photon emission computerized tomography (SPECT) to diagnose chronic diseases such as neurological, cardiovascular, chronic lung, and chronic kidney diseases. the availability of several radiotracer across the globe makes it selection easy depending on the type of disease and its prognosis. Thus, the increasing incidences of chronic diseases are surging the demand for radioactive tracer, positively favoring market expansion.

Asia Pacific Radioactive Tracer Market Overview

The Asia Pacific radioactive tracer market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. The market in the region is likely to continue to grow at the fastest rate during the forecast period owing to factors such as the development of new research facilities, the rise in the geriatric population and significant evolution of hybrid systems with technological advancement in the field of imaging.

Asia Pacific Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Radioactive Tracer Market Segmentation

The Asia Pacific radioactive tracer market is segmented based on tracer type, test type, end user, application, and country. Based on tracer type, the Asia Pacific radioactive tracer market is segmented into technetium-99m & Tc-97m, iodine-131, iron-59, lutetium-171, rubidium (Rb-82) chloride & ammonia (N-13), scandium-46, seaborgium-269, hassium-269, Gallium citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), phosphorus-32 & chromium-51, thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and others. The others segment held the largest market share in 2022.

Based on test type, the Asia Pacific radioactive tracer market is segmented into PET, SPECT, and others. The SPECT segment held the largest market share in 2022.

Based on end user, the Asia Pacific radioactive tracer market is segmented into hospitals & clinics, diagnostic centers, academic & research institutes, and others. The hospitals & clinics segment held the largest market share in 2022.

Based on application, the Asia Pacific radioactive tracer market is segmented into oncology, pulmonary, neurology, cardiology, and others. The oncology segment held the largest market share in 2022.

Based on country, the Asia Pacific radioactive tracer market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific radioactive tracer market share in 2022.

Rotem Industries Ltd, Invicro LLC, Cardinal Health Inc, Newcastle University, Novartis AG, Curium, and IBA Radiopharma Solutions are some of the leading players operating in the Asia Pacific radioactive tracer market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific radioactive tracer market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific radioactive tracer market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific radioactive tracer market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Radioactive Tracer Market - Key Industry Dynamics

  • 4.1 Key Market Drivers:
    • 4.1.1 Rising Prevalence of Chronic Diseases
    • 4.1.2 Increasing Use of Nuclear Imaging Techniques
  • 4.2 Market Restraints
    • 4.2.1 Short Shelf-Life of Radioactive Tracer
    • 4.2.2 Availability of Substitutes to Nuclear Diagnostic Imaging Procedures
  • 4.3 Market Opportunities
    • 4.3.1 Presence of Emerging Economies and Growing Population
    • 4.3.2 Development of Personalized Radiopharmaceuticals for Targeted Therapies
  • 4.4 Future Trends
    • 4.4.1 Use of Radioactive Tracer in Cancer Diagnosis
  • 4.5 Impact Analysis:

5. Radioactive Tracer Market - Asia Pacific Market Analysis

  • 5.1 Radioactive Tracer Market Revenue (US$ Mn), 2022 - 2030

6. Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 - by Tracer Types

  • 6.1 Overview
  • 6.2 Radioactive Tracer Market Revenue Share, by Tracer Types 2022 & 2030 (%)
  • 6.3 Technetium 99m and TC-97m
    • 6.3.1 Overview
    • 6.3.2 Technetium 99m and TC-97m: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Iodine 131
    • 6.4.1 Overview
    • 6.4.2 Iodine 131: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Iron 59
    • 6.5.1 Overview
    • 6.5.2 Iron 59: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Lutetium- 171
    • 6.6.1 Overview
    • 6.6.2 Lutetium- 171: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.7 RB82 and ammonia N-13
    • 6.7.1 Overview
    • 6.7.2 RB82 and ammonia N-13: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.8 Scandium 46
    • 6.8.1 Overview
    • 6.8.2 Scandium 46: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.9 Seaborgium-269
    • 6.9.1 Overview
    • 6.9.2 Seaborgium-269: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.10 Hassium -269
    • 6.10.1 Overview
    • 6.10.2 Hassium -269: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.11 Gallium Citrate GA 67
    • 6.11.1 Overview
    • 6.11.2 Gallium Citrate GA 67: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.12 PSMA GA68
    • 6.12.1 Overview
    • 6.12.2 PSMA GA68: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.13 FDDNP (F-18) and FDOPA (f-18)
    • 6.13.1 Overview
    • 6.13.2 FDDNP (F-18) and FDOPA (f-18): Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.14 Phosphorus 32 and Chromium -51
    • 6.14.1 Overview
    • 6.14.2 Phosphorus 32 and Chromium -51: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.15 Thallium-201
    • 6.15.1 Overview
    • 6.15.2 Thallium-201: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.16 F-18 FDG
    • 6.16.1 Overview
    • 6.16.2 F-18 FDG: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.17 F-18 FAPI
    • 6.17.1 Overview
    • 6.17.2 F-18 FAPI: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.18 GA 68 FAPI
    • 6.18.1 Overview
    • 6.18.2 GA 68 FAPI: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.19 F-18 PSMA
    • 6.19.1 Overview
    • 6.19.2 F-18 PSMA: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.20 DOTATOC/DOTANOC/DOTATATE Ga 68
    • 6.20.1 Overview
    • 6.20.2 DOTATOC/DOTANOC/DOTATATE Ga 68: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.21 Others
    • 6.21.1 Overview
    • 6.21.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 - by Test Type

  • 7.1 Overview
  • 7.2 Radioactive Tracer Market Revenue Share, by Test Type 2022 & 2030 (%)
  • 7.3 PET
    • 7.3.1 Overview
    • 7.3.2 PET: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 SPECT
    • 7.4.1 Overview
    • 7.4.2 SPECT: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 - by Application.

  • 8.1 Overview
  • 8.2 Radioactive Tracer Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Oncology
    • 8.3.1 Overview
    • 8.3.2 Oncology: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Pulmonary
    • 8.4.1 Overview
    • 8.4.2 Pulmonary: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Neurology
    • 8.5.1 Overview
    • 8.5.2 Neurology: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Cardiology
    • 8.6.1 Overview
    • 8.6.2 Cardiology: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 Radioactive Tracer Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Hospitals and Clinics
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Clinics: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Diagnostic Centers
    • 9.4.1 Overview
    • 9.4.2 Diagnostic Centers: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Academic and Research Institutes
    • 9.5.1 Overview
    • 9.5.2 Academic and Research Institutes: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Radioactive Tracer Market - Country Analysis

  • 10.1 Asia Pacific Radioactive Tracer Market, Revenue and Forecast to 2030
    • 10.1.1 Overview
    • 10.1.2 Asia Pacific Radioactive Tracer Market by Country
      • 10.1.2.1 China
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 China Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.1.3 China Radioactive Tracer Market, by Tracer Types
        • 10.1.2.1.4 China Radioactive Tracer Market, by Test Type
        • 10.1.2.1.5 China Radioactive Tracer Market, by Application
        • 10.1.2.1.6 China Radioactive Tracer Market, by End-User
      • 10.1.2.2 Japan
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 Japan Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.2.3 Japan Radioactive Tracer Market, by Tracer Types
        • 10.1.2.2.4 Japan Radioactive Tracer Market, by Test Type
        • 10.1.2.2.5 Japan Radioactive Tracer Market, by Application
        • 10.1.2.2.6 Japan Radioactive Tracer Market, by End-User
      • 10.1.2.3 India
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 India Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.3.3 India Radioactive Tracer Market, by Tracer Types
        • 10.1.2.3.4 India Radioactive Tracer Market, by Test Type
        • 10.1.2.3.5 India Radioactive Tracer Market, by Application
        • 10.1.2.3.6 India Radioactive Tracer Market, by End-User
      • 10.1.2.4 Australia
        • 10.1.2.4.1 Overview
        • 10.1.2.4.2 Australia Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.4.3 Australia Radioactive Tracer Market, by Tracer Types
        • 10.1.2.4.4 Australia Radioactive Tracer Market, by Test Type
        • 10.1.2.4.5 Australia Radioactive Tracer Market, by Application
        • 10.1.2.4.6 Australia Radioactive Tracer Market, by End-User
      • 10.1.2.5 South Korea
        • 10.1.2.5.1 Overview
        • 10.1.2.5.2 South Korea Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.5.3 South Korea Radioactive Tracer Market, by Tracer Type
        • 10.1.2.5.4 South Korea Radioactive Tracer Market, by Test Type
        • 10.1.2.5.5 South Korea Radioactive Tracer Market, by Application
        • 10.1.2.5.6 South Korea Radioactive Tracer Market, by End-User
      • 10.1.2.6 Rest of Asia Pacific
        • 10.1.2.6.1 Overview
        • 10.1.2.6.2 Rest of Asia Pacific Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.6.3 Rest of Asia Pacific Radioactive Tracer Market, by Tracer Types
        • 10.1.2.6.4 Rest of Asia Pacific Radioactive Tracer Market, by Test Type
        • 10.1.2.6.5 Rest of Asia Pacific Radioactive Tracer Market, by Application
        • 10.1.2.6.6 Rest of Asia Pacific Radioactive Tracer Market, by End-User

11. Radioactive Tracer Market Industry Landscape

  • 11.1 Overview
  • 11.2 Organic Developments
    • 11.2.1 Overview
  • 11.3 Inorganic Developments
    • 11.3.1 Overview

12. Radioactive Tracer Market, Key Company Profiles

  • 12.1 Rotem Industries Ltd
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Invicro LLC
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Cardinal Health Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Newcastle University
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Novartis AG
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Curium
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 General Electric Co
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 IBA Radiopharma Solutions
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Asia Pacific Radioactive Tracer Market Segmentation
  • Table 2. Principal Radionuclides Used in Radioactive Tracer
  • Table 3. China Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Tracer Types
  • Table 4. China Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Test Type
  • Table 5. China Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 6. China Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - End-User
  • Table 7. Japan Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Tracer Types
  • Table 8. Japan Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Test Type
  • Table 9. Japan Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 10. Japan Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - End-User
  • Table 11. India Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Tracer Types
  • Table 12. India Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Test Type
  • Table 13. India Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 14. India Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - End-User
  • Table 15. Australia Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Tracer Types
  • Table 16. Australia Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Test Type
  • Table 17. Australia Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Application
  • Table 18. Australia Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - End-User
  • Table 19. South Korea Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Tracer Type
  • Table 20. South Korea Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn) - Test Type
  • Table 21. South Korea Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 22. South Korea Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - End-User
  • Table 23. Rest of Asia Pacific Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Tracer Types
  • Table 24. Rest of Asia Pacific Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Test Type
  • Table 25. Rest of Asia Pacific Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 26. Rest of Asia Pacific Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - End-User
  • Table 27. Organic Developments Done by Companies
  • Table 28. Inorganic Developments Done by Companies
  • Table 29. Glossary of Terms, Asia Pacific Radioactive Tracer Market

List Of Figures

  • Figure 1. Asia Pacific Radioactive Tracer Market Segmentation, By Country
  • Figure 2. Asia Pacific Radioactive Tracer Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific Radioactive Tracer Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. Asia Pacific Radioactive Tracer Market Revenue Share, by Tracer Types 2022 & 2030 (%)
  • Figure 6. Technetium 99m and TC-97m: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Iodine 131: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Iron 59: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Lutetium- 171: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. RB82 and ammonia N-13: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Scandium 46: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Seaborgium-269: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Hassium -269: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Gallium Citrate GA 67: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. PSMA GA68: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. FDDNP (F-18) and FDOPA (f-18): Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Phosphorus 32 and Chromium -51: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Thallium-201: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. F-18 FDG: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. F-18 FAPI: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. GA 68 FAPI: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. F-18 PSMA: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. DOTATOC/DOTANOC/DOTATATE Ga 68: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Others: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Asia Pacific Radioactive Tracer Market Revenue Share, by Test Type 2022 & 2030 (%)
  • Figure 26. PET: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. SPECT: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Others: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Asia Pacific Radioactive Tracer Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 30. Oncology: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Pulmonary: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Neurology: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 33. Cardiology: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 34. Others: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 35. Asia Pacific Radioactive Tracer Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 36. Hospitals and Clinics: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 37. Diagnostic Centers: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 38. Academic and Research Institutes: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 39. Others: Asia Pacific Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 40. Asia Pacific Radioactive Tracer Market, By Country, 2022 ($Mn)
  • Figure 41. Asia Pacific Radioactive Tracer Market, By Key Countries, 2022 And 2030 (%)
  • Figure 42. China Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 43. Japan Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 44. India Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 45. Australia Radioactive Tracer Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 46. South Korea Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 47. Rest of Asia Pacific Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)